The influence of atrial fibrillation on the levels of NT-proBNP versus GDF-15 in patients with heart failure

被引：0

作者：

Bernadet T. Santema

Michelle M. Y. Chan

Jasper Tromp

Martin Dokter

Haye H. van der Wal

Johanna E. Emmens

Janny Takens

Nilesh J. Samani

Leong L. Ng

Chim C. Lang

Peter van der Meer

Jozine M. ter Maaten

Kevin Damman

Kenneth Dickstein

John G. Cleland

Faiez Zannad

Stefan D. Anker

Marco Metra

Pim van der Harst

Rudolf A. de Boer

Dirk J. van Veldhuisen

Michiel Rienstra

Carolyn S. P. Lam

Adriaan A. Voors

机构：

[1] University Medical Centre Groningen,Department of Cardiology, University of Groningen

[2] National Heart Centre Singapore,Department of Cardiology

[3] Singapore Duke-NUS Graduate Medical School,Department of Cardiovascular Sciences

[4] University of Leicester,Division of Molecular and Clinical Medicine, School of Medicine University of Dundee

[5] NIHR Leicester Biomedical Research Centre,National Heart & Lung Institute, Royal Brompton & Harefield Hospitals

[6] Glenfield Hospital,Robertson Institute of Biostatistics and Clinical Trials Unit

[7] Ninewells Hospital and Medical School,Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, Institute of Cardiology

[8] University of Bergen,undefined

[9] Stavanger University Hospital,undefined

[10] Imperial College,undefined

[11] University of Glasgow,undefined

[12] Inserm CIC 1433,undefined

[13] Université de Lorrain,undefined

[14] CHU de Nancy,undefined

[15] Department of Cardiology (CVK),undefined

[16] and Berlin Institute of Health Center for Regenerative Therapies (BCRT),undefined

[17] German Centre for Cardiovascular Research (DZHK) partner site Berlin,undefined

[18] Charité Universitätsmedizin,undefined

[19] University of Brescia,undefined

来源：

Clinical Research in Cardiology | 2020年 / 109卷

关键词：

Atrial fibrillation; Heart failure; Biomarkers; Natriuretic peptides; GDF-15;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：331 / 338

页数：7

共 358 条

[1]

Maisel A(2008)State of the art: using natriuretic peptide levels in clinical practice Eur J Heart Fail 68 2217-2228

[2]

Mueller C(2013)B-type natriuretic peptide and prognosis in heart failure patients with preserved and reduced ejection fraction J Am Coll Cardiol 8 482-487

[3]

Adams K(2002)Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure N Engl J Med 45 82-86

[4]

Anker SD(2016)Heart failure with preserved ejection fraction and atrial fibrillation: vicious twins J Am Coll Cardiol 126 1596-1604

[5]

Aspromonte N(2006)Natriuretic peptides in patients with atrial fibrillation and advanced chronic heart failure: determinants and prognostic value of (NT-)ANP and (NT-pro)BNP Europace 50 1054-1060

[6]

Cleland JGF(2005)Discordant atrial natriuretic peptide and brain natriuretic peptide levels in lone atrial fibrillation J Am Coll Cardiol 98 351-360

[7]

Cohen-Solal A(2019)Independent effect of atrial fibrillation on natriuretic peptide release Clin Res Cardiol 387 2302-2311

[8]

Dahlstrom U(2012)Prognostic utility of novel biomarkers of cardiovascular stress: the Framingham Heart Study Circulation. 6 96-104

[9]

DeMaria A(2016)Growth differentiation factor 15 in heart failure with preserved vs reduced ejection fraction Eur J Heart Fail 5 471-482

[10]

Di Somma S(2007)Prognostic utility of growth differentiation factor-15 in patients with chronic heart failure J Am Coll Cardiol 388 2895-2903

← 1 2 3 4 5 6 7 8 9 10 →